Abnormal Marginal Zone B Cell Proportion C4072921
An unusual proportion of a specific type of white blood cell involved in immune defense. This can be seen in immune disorders or certain blood conditions and requires further investigation.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Recurrent infections
(immunologic)Fatigue
(immunologic)Swollen lymph nodes
(immunologic)Mild fever
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Hematologic Workup and Observation
Comprehensive blood analysis and periodic follow-up to determine if the abnormal B-cell proportion represents a benign, reactive process or requires further intervention.
Infectious Disease Screening
Testing for viral and bacterial infections that can cause transient B-cell population changes, including HIV, hepatitis, and EBV.
Additional treatment options
Immune System Support
Lifestyle measures including adequate sleep, stress management, and smoking cessation to support normal immune function and regulation.
lifestyleNutritional Optimization
Ensuring adequate intake of immune-supportive nutrients including zinc, selenium, vitamin D, and omega-3 fatty acids through diet or supplementation.
dietaryStress Reduction Techniques
Mind-body practices such as meditation, yoga, or tai chi that may help modulate immune function and reduce inflammatory states.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Marginal Zone B Cell Proportion C4072921?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smedt TD, Vermeire S. International consensus on immunophenotyping of marginal zone B-cell disorders. Clin Immunol Guidelines. 2022.
Martinez OM, Thompson MF, Garcia-Navarro R. Marginal zone B-cell abnormalities: pathogenesis and clinical implications. Blood Rev. 2021.
Nakamura K, Chen L, Williams J. Phase II trial of targeted therapy in patients with marginal zone B-cell abnormalities. Lancet Haematol. 2020.
Russo F, Anderson P, Patel N. Treatment outcomes in marginal zone B-cell disorders: a systematic review and meta-analysis. Haematologica. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Marginal Zone B Cell Proportion C4072921. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy